Who Needs a Continuous Glucose Monitor
All patients with type 1 diabetes should use continuous glucose monitoring (CGM), regardless of age or current glycemic control, as this technology consistently reduces hypoglycemia and improves time in range without increasing adverse events. 1
Primary Indications for CGM
Type 1 Diabetes (Strongest Evidence)
- All children and adolescents with type 1 diabetes should be offered CGM, whether using multiple daily injections or insulin pumps, as benefits correlate directly with adherence to ongoing device use 1
- All adults with type 1 diabetes who are capable of using CGM daily should receive it, particularly when not meeting glycemic targets, experiencing hypoglycemia unawareness, or having recurrent hypoglycemic episodes 1
- Real-time CGM in pregnant women with type 1 diabetes effectively improves A1C levels, time in range, and neonatal outcomes 1
Type 2 Diabetes on Insulin Therapy
- Type 2 diabetes patients on intensive insulin therapy (≥3 injections daily or insulin pump) should use CGM to lower A1C and reduce hypoglycemia 1
- Hospitalized type 2 diabetes patients on insulin therapy in non-ICU settings benefit from real-time CGM to reduce glucose fluctuations and achieve stable glycemic targets without increasing hypoglycemia risk 1
- Perioperative glycemic control in type 2 diabetes patients is improved with real-time CGM 1
Type 2 Diabetes with Specific Glycemic Problems
CGM is indicated for type 2 diabetes patients using hypoglycemic therapy who experience any of the following 1:
- Unexplainable severe hypoglycemia, recurrent hypoglycemia, asymptomatic hypoglycemia, or nocturnal hypoglycemia
- Unexplainable hyperglycemia, especially fasting hyperglycemia
- Dramatic glycemic variability despite self-monitoring of blood glucose
- Patients who deliberately maintain high blood glucose due to fear of hypoglycemia
- HbA1c above target despite multidrug oral and/or non-insulin injectable therapies
Pregnancy-Related Diabetes
- Gestational diabetes patients and women with pre-existing diabetes during pregnancy should use CGM as an adjunct to pre- and postprandial blood glucose monitoring to achieve A1C targets and improve neonatal outcomes 1
- The American College of Obstetricians and Gynecologists specifically recommends CGM for pregnant women with type 1 diabetes with high-strength evidence 2
Special Clinical Situations
CGM is indicated for 1:
- Diabetes patients with gastroparesis
- Special types of diabetes with dramatic glycemic variability
- Endocrine disorders accompanied by dramatic glycemic variability
Educational and Behavioral Indications
Diabetes education purposes: CGM facilitates understanding of glucose changes from diet, exercise, alcohol, stress, sleep, and medications, motivating patients to establish healthy lifestyles and improving treatment adherence 1
Critical Prerequisites for CGM Use
Patient Capability Requirements
- Patients must be willing and able to learn the basic mechanical skills of the equipment, as optimal CGM use requires ongoing education and learning 1
- Robust diabetes education, training, and ongoing support are required for optimal implementation 1, 2
- Users need ability to perform self-monitoring of blood glucose for calibration (device-dependent) and verification of readings when discordant from symptoms 1
Usage Frequency for Effectiveness
- Real-time CGM devices should be used as close to daily as possible for maximal benefit 1
- Intermittently scanned CGM devices must be scanned at minimum once every 8 hours 1
- Benefits of CGM correlate directly with adherence to ongoing device use 1
Important Contraindications and Limitations
Where CGM Should NOT Be Used
- Intensive care units: Skin edema dilutes interstitial fluid glucose causing inaccurate results; vasoconstrictor drugs decrease skin blood flow and slow glucose shift from capillaries to interstitial fluid; hypotension, hypoxemia, and high-dose acetaminophen adversely affect sensor accuracy 1
Patient Selection Pitfalls
- CGM is not suitable for patients unwilling to learn device operation, as success depends on sustained use and proper data interpretation 1, 2
- Insufficient evidence exists for screening or diagnosis of prediabetes or diabetes 2
Technical Limitations to Counsel Patients About
- CGM measures interstitial fluid glucose, which lags behind blood glucose by 5-15 minutes during rapid changes 2
- Accuracy is lowest in hypoglycemic ranges, a critical limitation for patients with problematic hypoglycemia 2
- Sensor accuracy affected by medications, temperature, humidity, and altitude 2
- Skin reactions (irritation or allergy) should be assessed and addressed to aid successful device use 1, 2
- Avoid exposure to strong magnetic fields, MRI, and in some devices conventional X-ray and CT scanning 1
Periodic/Professional CGM Use
Periodic use of real-time, intermittently scanned, or professional CGM can be helpful when continuous use is not appropriate, desired, or available 1
Blinded CGM data, when coupled with diabetes self-management education and medication dose adjustment, helps identify and correct patterns of hyper- and hypoglycemia in both type 1 and type 2 diabetes 1